10-Q Filing

CELLDEX THERAPEUTICS, INC. CIK: 744218 Q2 2019

Filing Information

Form Type	10-Q
Accession Number	`0001104659-19-044531`
Period End Date	20190630
Filing Date	20190807
Fiscal Year	2019
Fiscal Period	Q2
XBRL Instance	cldx-20190630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 71 Income Statement 70 Cash Flow Statement 62

Balance Sheet 71 line items

Line Item	Tag	Value	Unit	Period
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$19.74M	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$43.89M	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$24.31M	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$40.29M	USD	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable Securities	`MarketableSecuritiesCurrent`	$61.60M	USD	Point-in-time
Marketable Securities	`MarketableSecuritiesCurrent`	$69.71M	USD	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts and Other Receivables	`AccountsAndOtherReceivablesNetCurrent`	$1.17M	USD	Point-in-time
Accounts and Other Receivables	`AccountsAndOtherReceivablesNetCurrent`	$3.16M	USD	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Prepaid and Other Current Assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.90M	USD	Point-in-time
Prepaid and Other Current Assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.85M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$99.08M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$84.36M	USD	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	14.82M	shares	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	11.96M	shares	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	14.82M	shares	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	11.96M	shares	Point-in-time
Property and Equipment, Net	`PropertyPlantAndEquipmentNet`	$6.11M	USD	Point-in-time
Property and Equipment, Net	`PropertyPlantAndEquipmentNet`	$5.09M	USD	Point-in-time
Operating Lease Right-of-Use Assets, Net	`OperatingLeaseRightOfUseAsset`	$3.97M	USD	Point-in-time
Intangible Assets, Net	`IntangibleAssetsNetExcludingGoodwill`	$48.69M	USD	Point-in-time
Intangible Assets, Net	`IntangibleAssetsNetExcludingGoodwill`	$48.69M	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$1.93M	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$129.00K	USD	Point-in-time
Total Assets	`Assets`	$155.81M	USD	Point-in-time
Total Assets	`Assets`	$142.24M	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$1.02M	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$1.07M	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$5.41M	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$7.01M	USD	Point-in-time
Current Portion of Operating Lease Liabilities	`OperatingLeaseLiabilityCurrent`	$2.54M	USD	Point-in-time
Current Portion of Other Long-Term Liabilities	`OtherLiabilitiesCurrent`	$2.54M	USD	Point-in-time
Current Portion of Other Long-Term Liabilities	`OtherLiabilitiesCurrent`	$4.53M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$11.51M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$12.60M	USD	Point-in-time
Long-Term Portion of Operating Lease Liabilities	`OperatingLeaseLiabilityNoncurrent`	$1.87M	USD	Point-in-time
Other Long-Term Liabilities	`OtherLiabilitiesNoncurrent`	$19.24M	USD	Point-in-time
Other Long-Term Liabilities	`OtherLiabilitiesNoncurrent`	$19.15M	USD	Point-in-time
Total Liabilities	`Liabilities`	$32.62M	USD	Point-in-time
Total Liabilities	`Liabilities`	$31.75M	USD	Point-in-time
Commitments and Contingent Liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingent Liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at June 30, 2019 and December 31, 2018	`PreferredStockValue`	-	USD	Point-in-time
Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at June 30, 2019 and December 31, 2018	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 14,816,917 and 11,957,635 Shares Issued and Outstanding at June 30, 2019 and December 31, 2018, Respectively	`CommonStockValue`	$15.00K	USD	Point-in-time
Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 14,816,917 and 11,957,635 Shares Issued and Outstanding at June 30, 2019 and December 31, 2018, Respectively	`CommonStockValue`	$12.00K	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$1.08B	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$1.10B	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.58M	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.64M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-991.46M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-962.44M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$109.63M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$124.06M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$112.69M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$134.09M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$128.05M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$236.37M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$155.81M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$142.24M	USD	Point-in-time

Income Statement 70 line items

Line Item	Tag	Value	Unit	Period
Total Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$6.83M	USD	2 Qtrs
Total Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.76M	USD	1 Quarter
Total Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$715.00K	USD	1 Quarter
Total Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.14M	USD	2 Qtrs
Research and Development	`ResearchAndDevelopmentExpense`	$21.45M	USD	1 Quarter
Research and Development	`ResearchAndDevelopmentExpense`	$43.32M	USD	2 Qtrs
Research and Development	`ResearchAndDevelopmentExpense`	$10.08M	USD	1 Quarter
Research and Development	`ResearchAndDevelopmentExpense`	$21.23M	USD	2 Qtrs
General and Administrative	`GeneralAndAdministrativeExpense`	$8.80M	USD	2 Qtrs
General and Administrative	`GeneralAndAdministrativeExpense`	$11.21M	USD	2 Qtrs
General and Administrative	`GeneralAndAdministrativeExpense`	$3.91M	USD	1 Quarter
General and Administrative	`GeneralAndAdministrativeExpense`	$5.62M	USD	1 Quarter
Goodwill Impairment	`GoodwillImpairmentLoss`	$90.98M	USD	2 Qtrs
Intangible Asset Impairment	`IntangibleAssetsImpairmentOtherThanGoodwill`	$18.68M	USD	2 Qtrs
Other Asset Impairment	`OtherAssetImpairmentCharges`	$1.80M	USD	2 Qtrs
(Gain)/Loss on Fair Value Remeasurement of Contingent Consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$-502.00K	USD	2 Qtrs
(Gain)/Loss on Fair Value Remeasurement of Contingent Consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$21.03M	USD	2 Qtrs
(Gain)/Loss on Fair Value Remeasurement of Contingent Consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$7.43M	USD	1 Quarter
(Gain)/Loss on Fair Value Remeasurement of Contingent Consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$1.02M	USD	1 Quarter
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	-	USD	1 Quarter
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	-	USD	2 Qtrs
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$224.00K	USD	2 Qtrs
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	-	USD	1 Quarter
Total Operating Expenses	`CostsAndExpenses`	$143.38M	USD	2 Qtrs
Total Operating Expenses	`CostsAndExpenses`	$19.64M	USD	1 Quarter
Total Operating Expenses	`CostsAndExpenses`	$32.34M	USD	2 Qtrs
Total Operating Expenses	`CostsAndExpenses`	$12.97M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-30.20M	USD	2 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-16.87M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-136.55M	USD	2 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-12.26M	USD	1 Quarter
Investment and Other Income, Net	`InterestAndOtherIncome`	$1.25M	USD	2 Qtrs
Investment and Other Income, Net	`InterestAndOtherIncome`	$466.00K	USD	1 Quarter
Investment and Other Income, Net	`InterestAndOtherIncome`	$478.00K	USD	1 Quarter
Investment and Other Income, Net	`InterestAndOtherIncome`	$1.18M	USD	2 Qtrs
Net Loss Before Income Tax Benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-29.02M	USD	2 Qtrs
Net Loss Before Income Tax Benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-135.30M	USD	2 Qtrs
Net Loss Before Income Tax Benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-16.41M	USD	1 Quarter
Net Loss Before Income Tax Benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-11.78M	USD	1 Quarter
Income Tax Benefit	`IncomeTaxExpenseBenefit`	$-765.00K	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-29.02M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-16.41M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-134.54M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-118.13M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-11.78M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-17.24M	USD	1 Quarter
Basic and Diluted Net Loss Per Common Share	`EarningsPerShareBasicAndDiluted`	$-0.84	USD	1 Quarter
Basic and Diluted Net Loss Per Common Share	`EarningsPerShareBasicAndDiluted`	$-1.67	USD	1 Quarter
Basic and Diluted Net Loss Per Common Share	`EarningsPerShareBasicAndDiluted`	$-14.01	USD	2 Qtrs
Basic and Diluted Net Loss Per Common Share	`EarningsPerShareBasicAndDiluted`	$-2.21	USD	2 Qtrs
Shares Used in Calculating Basic and Diluted Net Loss Per Share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	9.60M	shares	2 Qtrs
Shares Used in Calculating Basic and Diluted Net Loss Per Share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	13.95M	shares	1 Quarter
Shares Used in Calculating Basic and Diluted Net Loss Per Share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	9.83M	shares	1 Quarter
Shares Used in Calculating Basic and Diluted Net Loss Per Share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	13.13M	shares	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-29.02M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-16.41M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-134.54M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-118.13M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-11.78M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-17.24M	USD	1 Quarter
Unrealized Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$36.00K	USD	1 Quarter
Unrealized Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$19.00K	USD	1 Quarter
Unrealized Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$55.00K	USD	2 Qtrs
Unrealized Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-5.00K	USD	1 Quarter
Unrealized Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$26.00K	USD	2 Qtrs
Unrealized Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$31.00K	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-11.74M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-16.38M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-28.96M	USD	2 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-134.51M	USD	2 Qtrs

Cash Flow Statement 62 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-29.02M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-16.41M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-134.54M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-118.13M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-11.78M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-17.24M	USD	1 Quarter
Depreciation and Amortization	`DepreciationAmortization`	$2.50M	USD	2 Qtrs
Depreciation and Amortization	`DepreciationAmortization`	$2.02M	USD	2 Qtrs
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	-	USD	1 Quarter
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	-	USD	2 Qtrs
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$224.00K	USD	2 Qtrs
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	-	USD	1 Quarter
Amortization and Premium of Marketable Securities, Net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$652.00K	USD	2 Qtrs
Amortization and Premium of Marketable Securities, Net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$380.00K	USD	2 Qtrs
Loss on Sale or Disposal of Assets	`GainLossOnSaleOfPropertyPlantEquipment`	$-7.00K	USD	2 Qtrs
Loss on Sale or Disposal of Assets	`GainLossOnSaleOfPropertyPlantEquipment`	$-1.07M	USD	2 Qtrs
Goodwill Impairment	`GoodwillImpairmentLoss`	$90.98M	USD	2 Qtrs
Intangible Asset Impairment	`IntangibleAssetsImpairmentOtherThanGoodwill`	$18.68M	USD	2 Qtrs
Other Asset Impairment	`OtherAssetImpairmentCharges`	$1.80M	USD	2 Qtrs
Loss/(Gain) on Fair Value Remeasurement of Contingent Consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$-502.00K	USD	2 Qtrs
Loss/(Gain) on Fair Value Remeasurement of Contingent Consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$21.03M	USD	2 Qtrs
Loss/(Gain) on Fair Value Remeasurement of Contingent Consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$7.43M	USD	1 Quarter
Loss/(Gain) on Fair Value Remeasurement of Contingent Consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$1.02M	USD	1 Quarter
Non-Cash Income Tax Benefit	`IncomeTaxExpenseBenefit`	$-765.00K	USD	2 Qtrs
Stock-Based Compensation Expense	`ShareBasedCompensation`	$3.16M	USD	2 Qtrs
Stock-Based Compensation Expense	`ShareBasedCompensation`	$4.54M	USD	2 Qtrs
Accounts and Other Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$713.00K	USD	2 Qtrs
Accounts and Other Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-1.99M	USD	2 Qtrs
Prepaid and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$137.00K	USD	2 Qtrs
Prepaid and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-801.00K	USD	2 Qtrs
Accounts Payable and Accrued Expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-5.89M	USD	2 Qtrs
Accounts Payable and Accrued Expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-1.60M	USD	2 Qtrs
Other Liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-397.00K	USD	2 Qtrs
Other Liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-2.83M	USD	2 Qtrs
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-24.27M	USD	2 Qtrs
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-45.42M	USD	2 Qtrs
Sales and Maturities of Marketable Securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$106.18M	USD	2 Qtrs
Sales and Maturities of Marketable Securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$67.39M	USD	2 Qtrs
Purchases of Marketable Securities	`PaymentsToAcquireMarketableSecurities`	$76.90M	USD	2 Qtrs
Purchases of Marketable Securities	`PaymentsToAcquireMarketableSecurities`	$58.56M	USD	2 Qtrs
Acquisition of Property and Equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$484.00K	USD	2 Qtrs
Acquisition of Property and Equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$591.00K	USD	2 Qtrs
Net Cash Provided by Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$28.69M	USD	2 Qtrs
Net Cash Provided by Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$8.34M	USD	2 Qtrs
Net Proceeds from Stock Issuances	`ProceedsFromIssuanceOfCommonStock`	$19.96M	USD	2 Qtrs
Net Proceeds from Stock Issuances	`ProceedsFromIssuanceOfCommonStock`	$11.36M	USD	2 Qtrs
Proceeds from Issuance of Stock from Employee Benefit Plans	`ProceedsFromStockPlans`	$374.00K	USD	2 Qtrs
Proceeds from Issuance of Stock from Employee Benefit Plans	`ProceedsFromStockPlans`	$9.00K	USD	2 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$11.37M	USD	2 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$20.33M	USD	2 Qtrs
Net Increase/(Decrease) in Cash and Cash Equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$3.61M	USD	2 Qtrs
Net Increase/(Decrease) in Cash and Cash Equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-4.57M	USD	2 Qtrs
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$19.74M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$43.89M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$24.31M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$40.29M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$19.74M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$43.89M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$24.31M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$40.29M	USD	Point-in-time
Accrued construction in progress	`ConstructionInProgressExpendituresIncurredButNotYetPaid`	$55.00K	USD	2 Qtrs
Shares issued to former Kolltan executive for settlement of severance	`SharesIssuedToFormerKolltanExecutiveForSettlementOfSeverance`	$57.00K	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.